Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Correction for Scardino et al., Cancer Res 67 (14) 7028-7036.
Cancer Research 67, 7937-, August 15, 2007. doi: 10.1158/0008-5472.CAN-67-16-COR3
© 2007 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Corrections

Correction: Polyepitope DNA Vaccine and Tumor Challenge

In the article on polyepitope DNA vaccine and tumor challenge in the July 15, 2007 issue of Cancer Research (1), Poulam M. Patel should have been included as the 13th author, and the correct name of the 15th author is Andrew Mark Jackson. The correct affiliation for Dr. Patel and Dr. Jackson is Cancer Research UK Clinical Cancer Centre, Leeds, United Kingdom and Academic Division of Oncology, University of Nottingham, City Hospital, Nottingham, United Kingdom. Also, the correct affiliation for Steven G. Smith is Cancer Research UK Clinical Cancer Centre, Leeds, United Kingdom and London School of Tropical Hygiene and Infectious Disease, University of London, London, United Kingdom.

References

  1. Scardino A, Alimandi M, Correale P, Smith SG, Bei R, Firat H, Cusi MG, Faure O, Graf-Dubois S, Cencioni G, Marrocco J, Chouaib S, Patel PM, Lemonnier FA, Jackson AM, Kosmatopoulos K. A polyepitope DNA vaccine targeted to Her-2/ErbB-2 elicits a broad range of human and murine CTL effectors to protect against tumor challenge. Cancer Res 2007;67:7028–36.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online